ESPE Abstracts (2016) 86 P-P1-261

Johansson-Blizzard Syndrome with Pan-hypopituitrism, Type 2 Diabetes and Pancreatic insufficiency: Effect of Treatment

Fawzia Alyafiea & Ashraf Solimanb

aHamad Medical Center, Doha, Qatar; bUniversity of Alexandria, Alexandria, Egypt

Background: Johanson-Blizzard syndrome (JBS) is a disease characterized by poor growth, variable dysmorphic features, including aplasia or hypoplasia of the nasal alae, sensori-neural deafness, abnormal hair patterns or scalp defects, and oligodontia. Other features of JBS include pan-hypopituitarism, imperforate anus, and PI. Pancreatic endocrine insufficiency (PI).

Case study: AM is a 10 years-old boy, born at term with aplasia of the alae nasi and congenital sensori-neural deafness, severe prenatal growth retardation and mental retardation. He presented at the age of 1.5 year with severe post-natal growth retardation and PI. He was started on Pancrex. Endocrine tests showed low TSH and FT4 and cortisol deficiency. He was started on L-thyroxine and hydrocortisone. In spite of his weight gain his linear growth was slow. At 2 years his peak GH responses to glucagon and clonidine stimulation tests were 3 and 5 ng/ml respectively with low IGF-I. MRI head showed hypoplastic pituitary gland. GH therapy was started and at that time he was dignosed genetiaclly with JBS. At 7 years he attained complete catch up growth (Height at 50th centile for age) At 10 years of age his random blood glucose (RBS) was noticed to be abnormal 8.5 mmol/l. OGTT showed fasting hyperglycemia and post prandial hyperglycemia (Table 1) he did not have acanthosis or goiter and the other systemic examination showed no new findings. He was prepubertal. Oral glucose tolerance test with insulin measurement showed hyperglycemia and high insulin secretion (insulin resistance). The diagnosis of Type 2 DM was given. Oral metformin 500 mg twice daily was prescribed with excellent response to the treatment (table). After a year on treatment his HbA1C=5.9%.

Discussion: DM is a rare complication of JBS with only three cases reported in the literature, two of which had history of pancreatic exocrine insufficiency and found to have insulin deficiency. The third case had DM with insulin resistance without pancreatic exocrine insufficiency. This is the first case with pan-hypopituitarism, type 2 DM in a pancreatic insufficient JBS patient.

Summary: In this patient with JBS and type 2 DM glycemic control was successfully achieved with oral Metformin.

Table 1.
Fasting 2 h prandial
Glucose (mmol/L)7.1 17.4
Insulin (μunit/ml)19 48
Cpeptide (ng/ml)3 5.88

Article tools

My recent searches

No recent searches.